Induction chemotherapy
Induction chemotherapy is the first-line treatment of cancer with a chemotherapeutic drug. The goal of induction chemotherapy is to cure the cancer.[1] It may be contrasted with neoadjuvant therapy, with consolidation chemotherapy (intended to kill any cancer cells that survived the initial treatment), and with maintenance chemotherapy given at lower doses after the consolidation phase of treatment is over.[2]
| Induction chemotherapy | |
|---|---|
| Specialty | oncology |
Induction chemotherapy relies on the principle of spatial cooperation. It is beneficial in the control of malignant lymphomas and head and neck squamous cell carcinomas when followed by radiotherapy or when treated concurrently with chemoradiotherapy.[3]
References
- Schmaier, Alvin H. (2003). Hematology for the Medical Student. Philadelphia: Lippincott Williams & Wilkins. pp. 180. ISBN 0781731208.
- "Chemotherapy for Acute Myeloid Leukemia (AML)".
- Vokes, E. E. (2010). "Induction Chemotherapy for Head and Neck Cancer: Recent Data". The Oncologist. 15: 3–7. doi:10.1634/theoncologist.2010-S3-03. PMID 21036882.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.